Arctic Research Commission

  • Notice of 108th Commission Meeting

    A notice by the U.S. Arctic Research Commission on 10/10/2017.

    Notice is hereby given that the U.S. Arctic Research Commission will hold its 108th meeting in Anchorage, AK, on October 10, 2017. The business sessions, open to the public, will convene at 8:00 a.m. at the Hotel Captain Cook, 939 W 5th Ave., Anchorage, AK 99501.

    The Agenda items include:

    (1) Call to order and approval of the agenda (2) Approval of the minutes from the 106th meeting (3) Commissioners and staff reports (4) Discussion and presentations concerning Arctic research activities

    The meeting will focus on reports and updates relating to programs and research projects affecting Alaska and the greater Arctic.

    The Arctic Research and Policy Act of 1984 (Title I Pub. L. 98-373) and the Presidential Executive Order on Arctic Research (Executive Order 12501) dated January 28, 1985, established the United States Arctic Research Commission.

    If you plan to attend this meeting, please notify us via the contact information below. Any person planning to attend who requires special accessibility features and/or auxiliary aids, such as sign language interpreters, must inform the Commission of those needs in advance of the meeting.

    Contact person for further information: Kathy Farrow, Communications Specialist, U.S. Arctic Research Commission, 703-525- 0111 or TDD 703-306-0090.

    https://www.gpo.gov/fdsys/pkg/FR-2017-09-18/html/2017-19798.htm

  • Health and Human Services

  • 2017 Scientific Meeting of the National Antimicrobial Resistance Monitoring System; Public Meeting; Request for Comments

    AGENCY: Food and Drug Administration, HHS.

    ACTION: Notice of public meeting; request for comments.


    SUMMARY: The Food and Drug Administration (FDA, the Agency, or we), together with the NARMS partner agencies, is announcing a public meeting entitled "2017 Scientific Meeting of the National Antimicrobial Resistance Monitoring System.'' The purpose of the public meeting is to discuss the current status of the National Antimicrobial Resistance Monitoring System (NARMS) and directions for the future.

    DATES: The public meeting will be held on October 24 and 25, 2017, from 8:30 a.m. to 5 p.m. Eastern Time. Submit either electronic or written comments on this public meeting by November 24, 2017. See the SUPPLEMENTARY INFORMATION section for registration date and information.

    ADDRESSES: The public meeting will be held at the Jefferson Auditorium in the South Building, U.S. Department of Agriculture (USDA), 14th and Independence Avenue SW., Washington, DC 20250. The South Building is a Federal facility, and attendees should plan adequate time to pass through the security screening systems. Attendance is free. Non-USDA employees must enter through the Wing 3 entrance on Independence Avenue. Attendees must be pre-registered for the meeting (and check-in outside the day of the meeting) and show a valid photo ID to enter the building. Only registered attendees will be permitted to enter the building. For parking and security information, please refer to https://smithsonianassociates.org/ticketing/help/locations/jefferson.htm.

    You may submit comments as follows. Please note that late, untimely filed comments will not be considered. Electronic comments must be submitted on or before November 24, 2017. The https://www.regulations.gov electronic filing system will accept comments until midnight Eastern Time at the end of November 24, 2017. Comments received by mail/hand delivery/courier (for written/paper submissions) will be considered timely if they are postmarked or the delivery service acceptance receipt is on or before that date.

    Electronic Submissions

    Submit electronic comments in the following way:

    Federal eRulemaking Portal: https://www.regulations.gov. Follow the instructions for submitting comments. Comments submitted electronically, including attachments, to https://www.regulations.gov will be posted to the docket unchanged. Because your comment will be made public, you are solely responsible for ensuring that your comment does not include any confidential information that you or a third party may not wish to be posted, such as medical information, your or anyone else's Social Security number, or confidential business information, such as a manufacturing process. Please note that if you include your name, contact information, or other information that identifies you in the body of your comments, that information will be posted on https://www.regulations.gov.

    If you want to submit a comment with confidential information that you do not wish to be made available to the public, submit the comment as a written/paper submission and in the manner detailed (see "Written/Paper Submissions'' and "Instructions'').

    Written/Paper Submissions

    Submit written/paper submissions as follows:

    Mail/Hand Delivery/Courier (for written/paper submissions): Dockets Management Staff (HFA-305), Food and Drug Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852.

    For written/paper comments submitted to the Dockets Management Staff, FDA will post your comment, as well as any attachments, except for information submitted, marked and identified, as confidential, if submitted as detailed in "Instructions.''

    Instructions: All submissions received must include the Docket No. FDA-2017-N-5056 for "2017 Scientific Meeting of the National Antimicrobial Resistance Monitoring System; Public Meeting; Request for Comments.'' Received comments, those filed in a timely manner (see ADDRESSES), will be placed in the docket and, except for those submitted as "Confidential Submissions,'' publicly viewable at https://www.regulations.gov or at the Dockets Management Staff between 9 a.m. and 4 p.m., Monday through Friday.

    Confidential Submissions--To submit a comment with confidential information that you do not wish to be made publicly available, submit your comments only as a written/paper submission. You should submit two copies total. One copy will include the information you claim to be confidential with a heading or cover note that states "THIS DOCUMENT CONTAINS CONFIDENTIAL INFORMATION.'' The Agency will review this copy, including the claimed confidential information, in its consideration of comments. The second copy, which will have the claimed confidential information redacted/blacked out, will be available for public viewing and posted on https://www.regulations.gov. Submit both copies to the Dockets Management Staff. If you do not wish your name and contact information to be made publicly available, you can provide this information on the cover sheet and not in the body of your comments and you must identify this information as "confidential.'' Any information marked as "confidential'' will not be disclosed except in accordance with 21 CFR 10.20 and other applicable disclosure law. For more information about FDA's posting of comments to public dockets, see 80 FR 56469, September 18, 2015, or access the information at: https://www.gpo.gov/fdsys/pkg/FR-2015-09-18/pdf/2015-23389.pdf.

    Docket: For access to the docket to read background documents or the electronic and written/paper comments received, go to https://www.regulations.gov and insert the docket number, found in brackets in the heading of this document, into the "Search'' box and follow the prompts and/or go to the Dockets Management Staff, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852.

    FOR FURTHER INFORMATION CONTACT: Laura Bradbard, Center for Veterinary Medicine, Food and Drug Administration, 7500 Standish Pl. (HFV-1), Rockville, MD 20855, 240-402-5672, email: laura.bradbard@fda.hhs.gov.

    https://www.gpo.gov/fdsys/pkg/FR-2017-09-21/html/2017-20108.htm

  • Solicitation of Nominations for Appointment to the Healthcare Infection Control Practices Advisory Committee (HICPAC)

    ACTION: Notice.


    SUMMARY: The Centers for Disease Control and Prevention (CDC) is seeking nominations for membership on the HICPAC. The HICPAC consists of 14 experts in fields including but not limited to, infectious diseases, infection prevention, healthcare epidemiology, nursing, clinical microbiology, surgery, hospitalist medicine, internal medicine, epidemiology, health policy, health services research, public health, and related medical fields. Nominations are being sought for individuals who have expertise and qualifications necessary to contribute to the accomplishments of the committee's objectives. Nominees will be selected based on expertise in the fields of infectious diseases, infection prevention, healthcare epidemiology, nursing, environmental and clinical microbiology, surgery, internal medicine, epidemiology, health policy, health services research, and public health. Federal employees will not be considered for membership. Members may be invited to serve for four-year terms. Selection of members is based on candidates' qualifications to contribute to the accomplishment of HICPAC objectives https://www.cdc.gov/hicpac/.

    DATES: Nominations for membership on the HICPAC be received no later than November 30, 2017. Packages received after this time will not be considered for the current membership cycle.

    ADDRESSES: All nominations should be mailed to HICPAC, Division of Healthcare Quality Promotion, NCEZID, CDC, 1600 Clifton Road NE., Mailstop A-07, Atlanta, Georgia 30333, emailed (recommended) to hicpac@cdc.gov, or faxed to (404) 639-4043.

    FOR FURTHER INFORMATION CONTACT: Erin Stone, M.S., HICPAC, Division of Healthcare Quality Promotion, NCEZID, CDC, 1600 Clifton Road NE., Mailstop A-07, Atlanta, Georgia 30333; Telephone (404) 639-4045; hicpac@cdc.gov.

    https://www.gpo.gov/fdsys/pkg/FR-2017-09-18/html/2017-19501.htm

  • National Science Foundation

  • Advisory Committee for Polar Programs; Notice of Meeting

    In accordance with the Federal Advisory Committee Act (Pub. L. 92- 463, as amended), the National Science Foundation (NSF) announces the following meeting:

    Name and Committee Code: Advisory Committee for Polar Programs (1130).

    Date and Time: October 19, 2017, 2:00 p.m.-6:00 p.m., October 20, 2017, 9:00 a.m.-2:00 p.m.

    Place: National Science Foundation, 2415 Eisenhower Avenue, Alexandria, Virginia 22314, Room C 2010 (October 19) and E 2020 (October 20).

    Type of Meeting: Open.

    Contact Person: Andrew Backe, National Science Foundation, Room W 7134, 2415 Eisenhower Avenue, Alexandria, Virginia 22314; Phone 703- 292-2454.

    Minutes: May be obtained from the contact person listed above.

    Purpose of Meeting: To provide advice and recommendations to the National Science Foundation concerning support for polar research, education, infrastructure and logistics, and related activities.

    Agenda

    October 19, 2017; 2 p.m.-6:00 p.m.

    • Opening Remarks and Introductions
    • Harassment Policy
    • Polar Data/Cyberinfrastructure
    • Antarctic Infrastructure Modernization for Science (AIMS)
    • Strategic Planning--Part 1

    October 20, 2017; 9 a.m.-2 p.m.

    • Community Engagement in Research in Alaska
    • Navigating the New Arctic
    • Strategic Planning--Part 2
    • Meeting with the NSF Director and COO
    • Thwaites Project
    • Wrap-up and Action Items

    https://www.gpo.gov/fdsys/pkg/FR-2017-09-21/html/2017-20123.htm

back to Federal Register Resource

Bookmark and Share


Trending News

Latest Twitter

Newsletter

Subscribe to our newsletter, sent out every month.